Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-10-04 Purchase | 2022-10-06 08:30 am | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 346 | $0.57 | $197 | 178,415 (Indirect Direct) | View |
| 2022-09-26 Purchase | 2022-09-27 08:01 am | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 18,867 | $0.55 | $10,377 | 178,069 (Indirect Direct) | View |
| 2022-02-14 Purchase | 2022-02-22 4:59 pm | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 3,000 | $4.4 | $13,200 | 159,202 (Indirect Direct) | View |
| 2022-02-08 Purchase | 2022-02-10 5:05 pm | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 2,000 | $4.835 | $9,670 | 156,202 (Indirect Direct) | View |
| 2022-02-03 Purchase | 2022-02-07 09:00 am | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 6,000 | $5.125 | $30,750 | 154,202 (Indirect Direct) | View |
| 2022-01-27 Purchase | 2022-01-31 5:50 pm | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 5,000 | $5.303 | $26,515 | 148,202 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-30 Disposition | 2024-10-02 9:53 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO | 572,182 | $0 | 5,795,408 (Direct) | View |
| 2024-09-25 Exercise | 2024-10-02 9:53 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO | 275 | $1000 | 5,795,408 (Direct) | View |
| 2024-09-25 Exercise | 2024-10-02 9:53 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO | 5,312,983 | $0 | 5,795,408 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-13 6:25 pm | N/A 2034-06-12 | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 800 | $0 | 800 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 9:27 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 572,182 | $0 | 572,182 (Direct) | View |
| 2024-02-19 Option Award | 2024-02-21 5:25 pm | N/A 2034-02-18 | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2024-02-14 Other | 2024-02-16 7:37 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 1,730 | $1000 | 6,268,026 (Indirect) | View |
| 2024-02-14 Option Award | 2024-02-16 7:37 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 100 | $1000 | 6,268,026 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 7:37 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 1,555 | $1000 | 6,268,026 (Indirect) | View |
| 2024-02-14 Other | 2024-02-16 7:37 pm | 2024-03-15 2029-02-14 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 6,133,669 | $0 | 6,268,026 (Indirect) | View |
| 2024-02-14 Exercise | 2024-02-16 7:37 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 0 | $0 | 6,268,026 (Indirect) | View |
| 2023-06-22 Option Award | 2023-06-22 8:09 pm | N/A 2033-06-21 | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:07 pm | N/A 2033-01-19 | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 35,938 | $0 | 35,938 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 6:39 pm | N/A 2032-06-08 | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-10-08 Other | 2021-10-12 7:36 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Ehrlich Christopher B CEO and Secretary 10% Owner | 101,241 | $0 | 5,682,977 (Indirect) | View |
| 2021-10-08 Other | 2021-10-12 7:36 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Ehrlich Christopher B CEO and Secretary 10% Owner | 36,733 | $10 | 5,682,977 (Indirect) | View |
| 2021-10-06 Option Award | 2021-10-08 5:22 pm | N/A 2031-10-05 | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2021-10-05 6:54 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Ehrlich Christopher B CEO and and Secretary 10% Owner | 0 | $0 | 5,674,020 (Indirect) | View |
| 2021-08-25 Disposition | 2021-08-27 6:53 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 133,798 | $0 | 144,236 (Indirect) | View |
| 2021-08-25 Conversion | 2021-08-27 6:53 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Ehrlich Christopher B Director | 143,202 | $0 | 144,236 (Indirect) | View |
| 2021-01-12 Other | 2021-01-14 7:46 pm | N/A N/A | Locust Walk Acquisition Corp. | LWAC | Ehrlich Christopher B See Remarks | 23,750 | $0 | 4,511,250 (Indirect) | View |
Ownership | 2021-01-07 8:50 pm | N/A N/A | Locust Walk Acquisition Corp. | LWAC | Ehrlich Christopher B Chief Executive Officer 10% Owner | 0 | $0 | 5,261,667 (Indirect) | View |